Naski M C, Shafer J A
Department of Biological Chemistry, University of Michigan, Ann Arbor 48109.
J Biol Chem. 1991 Jul 15;266(20):13003-10.
In this study we report a kinetic model for the alpha-thrombin-catalyzed production of fibrin I and fibrin II at pH 7.4, 37 degrees C, gamma/2 0.17. The fibrin is produced by the action of human alpha-thrombin on plasma levels of human fibrinogen in the presence of the major inhibitor of alpha-thrombin in plasma, antithrombin III (AT). This model quantitatively accounts for the time dependence of alpha-thrombin-catalyzed release of fibrinopeptides A and B concurrent with the inactivation of alpha-thrombin by AT and delineates the concerted interactions of alpha-thrombin, fibrin(ogen), and AT during the production of a fibrin clot. The model also provides a method for estimating the concentration of alpha-thrombin required to produce a clot of known composition and predicts a direct relationship between the plasma concentration of fibrinogen and the amount of fibrin produced by a bolus of alpha-thrombin. The predicted relationship between the concentration of fibrinogen and the amount of fibrin produced in plasma provides a plausible explanation for the observed linkage between plasma concentrations of fibrinogen and the risk for ischemic heart disease.
在本研究中,我们报告了一种动力学模型,用于描述在pH 7.4、37摄氏度、γ/2为0.17的条件下,α-凝血酶催化生成纤维蛋白I和纤维蛋白II的过程。纤维蛋白是在血浆中α-凝血酶的主要抑制剂抗凝血酶III(AT)存在的情况下,由人α-凝血酶作用于人纤维蛋白原的血浆水平而产生的。该模型定量地解释了α-凝血酶催化纤维蛋白肽A和B释放的时间依赖性,以及同时发生的α-凝血酶被AT灭活的过程,并描述了在纤维蛋白凝块形成过程中α-凝血酶、纤维蛋白(原)和AT之间的协同相互作用。该模型还提供了一种方法,用于估计产生已知组成凝块所需的α-凝血酶浓度,并预测纤维蛋白原的血浆浓度与一次注射α-凝血酶产生的纤维蛋白量之间的直接关系。纤维蛋白原浓度与血浆中产生的纤维蛋白量之间的预测关系,为观察到的纤维蛋白原血浆浓度与缺血性心脏病风险之间的联系提供了一个合理的解释。